Farzad Nazem - Net Worth and Insider Trading

Farzad Nazem Net Worth

The estimated net worth of Farzad Nazem is at least $12 Million dollars as of 2024-04-26. Farzad Nazem is the EVP & Chief Technology Officer of Altaba Inc and owns about 612,362 shares of Altaba Inc (AABA) stock worth over $12 Million. Details can be seen in Farzad Nazem's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Farzad Nazem has not made any transactions after 2007-05-21 and currently still holds the listed stock(s).

Transaction Summary of Farzad Nazem

To

Farzad Nazem Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Farzad Nazem owns 1 companies in total, including Nautilus Biotechnology Inc (NAUT) .

Click here to see the complete history of Farzad Nazem’s form 4 insider trades.

Insider Ownership Summary of Farzad Nazem

Ticker Comapny Transaction Date Type of Owner
NAUT Nautilus Biotechnology Inc 2021-06-09 director

Farzad Nazem Latest Holdings Summary

Farzad Nazem currently owns a total of 1 stock. Farzad Nazem owns 612,362 shares of Altaba Inc (AABA) as of May 21, 2007, with a value of $12 Million.

Latest Holdings of Farzad Nazem

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AABA Altaba Inc 2007-05-21 612,362 19.63 12,020,666

Holding Weightings of Farzad Nazem


Farzad Nazem Form 4 Trading Tracker

According to the SEC Form 4 filings, Farzad Nazem has made a total of 0 transactions in Altaba Inc (AABA) over the past 5 years. The most-recent trade in Altaba Inc is the sale of 84,500 shares on May 21, 2007, which brought Farzad Nazem around $3 Million.

Insider Trading History of Farzad Nazem

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Farzad Nazem Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Farzad Nazem Ownership Network

Ownership Network List of Farzad Nazem

No Data

Ownership Network Relation of Farzad Nazem


Farzad Nazem Owned Company Details

What does Nautilus Biotechnology Inc do?

Who are the key executives at Nautilus Biotechnology Inc?

Farzad Nazem is the director of Nautilus Biotechnology Inc. Other key executives at Nautilus Biotechnology Inc include director & 10 percent owner & CEO & President & and Secretary Sujal M Patel , Senior VP & Product Development Subramanian Sankar , and Chief People Officer Gwen E Weld .

Nautilus Biotechnology Inc (NAUT) Insider Trades Summary

Over the past 18 months, Farzad Nazem made no insider transaction in Nautilus Biotechnology Inc (NAUT). Other recent insider transactions involving Nautilus Biotechnology Inc (NAUT) include a net purchase of 50,000 shares made by Sujal M Patel ,

In summary, during the past 3 months, insiders sold 0 shares of Nautilus Biotechnology Inc (NAUT) in total and bought 50,000 shares, with a net purchase of 50,000 shares. During the past 18 months, 0 shares of Nautilus Biotechnology Inc (NAUT) were sold and 50,000 shares were bought by its insiders, resulting in a net purchase of 50,000 shares.

Nautilus Biotechnology Inc (NAUT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nautilus Biotechnology Inc Insider Transactions

No Available Data

Farzad Nazem Mailing Address

Above is the net worth, insider trading, and ownership report for Farzad Nazem. You might contact Farzad Nazem via mailing address: C/o Yahoo Inc, 701 First Ave, Sunnyvale Ca 94089.

Discussions on Farzad Nazem

No discussions yet.